AcuityMD Flywheel 2026

Dave Carey is a 30-year MedTech commercial leader and CEO of Preceptis Medical, where he is leading the company's next phase of growth and commercialization of the Hummingbird Tympanostomy Tube System. Prior to Preceptis, Dave held leadership roles at Medtronic, Stryker, Invuity, and Pristine Surgical, including General Manager of Stryker New England and Chief Commercial Officer at Pristine Surgical.

Find Dave Carey on LinkedIn

Christopher Conicelli is Area Vice President at Baxter, where he leads the East area for the company’s Advanced Surgery business. A registered nurse by training, he has spent nearly two decades at Baxter, and he brings a perspective shaped by both the clinical reality his teams sell into and the commercial discipline required to run a large field organization.

Chris returns to Flywheel after speaking in 2024, when he shared how Baxter's Advanced Surgery team moved off a company-wide legacy CRM and built a commercial process their top performers actually wanted to use. His work centers on rep adoption, data his leaders can trust, and the change management that makes new tools stick across a distributed sales team.

Find Christopher Conicelli on LinkedIn

Mark Copeland is a 30-year medical sales person with 21 years of small medical device sales and a trusted advisor to small medical device sales and commercialization leaders.

One of the original Globus Medical Senior Sales Territory Managers, Mark exited at Globus’ IPO and started 10X Medical with two other medical device experts. 10X (and later 3T Medical) focused on innovative medical device sales in operating rooms, ICUs, NICUs and emergency departments.

While leading a small team of W2 reps and calling on his accounts, Mark gained immeasurable experience selling early stage companies with little market penetration, and mastered a process and approach to selling into ASCs, hospitals and health systems without the benefit of brand recognition or GPO status. 

Mark’s Value Analysis Sales approach has been honed and perfected over 15 years. Mark’s method sells into health systems across the country by getting the Value Analysis Committee the required information in a format Value Analysis welcomes.

Mark now consults for small medical device companies who may be struggling to get their new product requests approved or are looking for an edge in today's competitive ASC and hospital landscape. Mark still sells into health systems currently and is a practitioner of the process he teaches.

Regardless of the clinical end users (OR, ER, ICU, NICU and anywhere else small medical devices belong) Mark demystifies new product requests so that products gets into the hands of end users faster and at higher average sales prices.

Find Mark Copeland on LinkedIn

Hani Elias is a healthcare entrepreneur who builds companies designed to improve the cost, quality, and experience of patient care. He is the co-founder and CEO of Leap Health, whose mission is to make life-changing specialty medicine accessible without unnecessary cost or complexity. Previously, Hani was the co-founder and CEO of Lumere, a venture-backed healthcare technology company that helped health systems reduce unwarranted clinical variation and lower the cost of care. Lumere was acquired by GHX in 2020. Earlier in his career, he worked at McKinsey & Company in Dubai, focused on healthcare delivery and reform across the Gulf Cooperation Council.

Find Hani Elias on LinkedIn

Sarah Keenan is VP of Commercial Excellence at Route 92 Medical, where she leads the commercial excellence function across sales strategy, KOL development, training, and sales operations. She built the commercial infrastructure that carried the company through a doubling of its commercial team, work that improved forecast accuracy from 63% to 97% and brought new hires up to speed on pipeline and forecasting within two months. She is a graduate of the Gies College of Business at the University of Illinois Urbana-Champaign.

Find Sarah Keenan on LinkedIn

Justin Migliaccio works in Commercial Marketing at PROCEPT BioRobotics, focusing on the commercialization of their HYDROS robotic platform. Previously, he held global commercial and business strategy roles for Intuitive Surgical’s robotic platforms portfolio. He began his career in MedTech investment banking and is a graduate of the Georgia Institute of Technology.

Find Justin Migliaccio on LinkedIn

Michael Monovoukas is the co-founder and CEO of AcuityMD. Prior to launching AcuityMD, he was a Medtech entrepreneur. He also held a leadership role at PatientPing, a leading provider of care coordination software.

Michael started his career as a management consultant at Bain & Company, where he advised leading life sciences companies on growth and commercial strategy. Michael received his M.B.A. from Harvard Business School and his B.A. in Public Policy and Finance from Princeton University.

Find Mike Monovoukas on LinkedIn

Alex Wakefield is the Chief Revenue Officer at AcuityMD, a platform that enables medical device companies to focus their commercial efforts and drive revenue growth throughout the product lifecycle. At AcuityMD, Alex oversees the sales, consulting, and customer success teams, bringing a customer-first mindset to every stage of the business.

With more than 25 years of leadership experience, Alex has successfully scaled SaaS companies across logistics, life sciences, and supply chain industries. His track record of building high-performance teams and driving sustained growth has made him a trusted leader in the MedTech space.

Find Alex Wakefield on LinkedIn

Tyler Wunder is Director, Commercial Excellence at Baxter International Inc., where he leads the team's work on territory planning, pipeline management, and field adoption of commercial tools. He holds a BS from the University of Illinois Urbana-Champaign and an MBA from Indiana University's Kelley School of Business.

Find Tyler Wunder on LinkedIn